Riskpilot← Back to searchSign inGet full accessAGRENIUS LUNGMEDICIN AB
ABActiveOrg 5566142500Medical specialists activities · NACE 8622Est. 20010 employees
Revenue 2025
SEK 574K
-5% vs 2024
EBITDA margin
-4.2%
-500% vs 2024
Equity ratio
75.9%
Financial strength
Net profit 2025
SEK 517K
+197% vs 2024
| Revenue | SEK 574K | -5% |
| EBITDA | SEK -24K | -500% |
| Net profit | SEK 517K | +197% |
| Total assets | SEK 3,4M | +8% |
| Equity | SEK 2,6M | +14% |
| Employees | 0 | — |
Legal name
AGRENIUS LUNGMEDICIN AB
Org number
5566142500
Legal form
Aktiebolag
NACE code
8622 · Medical specialists activities
Founded
30 juli 2001
Share capital
SEK 100 000
Employees
0
VAT registered
No
Audit selected
No
Last report
2025-06-30
Financial year
January – December
Signatory rights
Firman tecknas av styrelsen
Company purpose
Bolaget skall bedriva läkarpraktik samt idka handel med värdepapper och därmed förenlig verksamhet.
Address
Email
veronica.agrenius@gmail.com
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Revenue | 1 077 | 1 112 | 691 | 605 | 574 |
| Staff expenses | — | −814 | −446 | −528 | −542 |
| EBITDA | 102 | 105 | 108 | −4 | −24 |
| Depreciation & amort. | −0 | — | — | — | — |
| EBIT | 102 | 105 | 108 | −4 | −24 |
| Net financials | 531 | 295 | −46 | 76 | 549 |
| Profit before tax | 639 | 499 | 345 | 226 | 591 |
| Tax | −142 | −106 | −88 | −52 | −74 |
| Net profit | 497 | 393 | 257 | 174 | 517 |
| Item | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Total assets | 3 655 | 3 665 | 3 238 | 3 133 | 3 381 |
| Equity | 2 181 | 2 312 | 2 305 | 2 258 | 2 566 |
| Long-term debt | 0 | — | — | — | — |
| Short-term debt | 334 | 312 | 175 | 271 | 277 |
| Total debt | 334 | 312 | 175 | 271 | 277 |
EBITDA margin
-4.2%
This company
15.8%
Market median
-127% vs market
20212025
Equity ratio
75.9%
This company
38.2%
Market median
+99% vs market
20212025
Return on equity
20.1%
This company
18.4%
Market median
+9% vs market
20212025
Net profit margin
90.1%
This company
8.1%
Market median
+1012% vs market
20212025
Asset turnover
0.17×
This company
1.12×
Market median
-85% vs market
20212025
Debt / equity
0.32×
This company
0.62×
Market median
+48% vs market
20212025
- Annual report 2025Filed via Bolagsverket / SCB · Period 2024-07-01 – 2025-06-30
- Annual report 2024Filed via Bolagsverket / SCB · Period 2023-07-01 – 2024-06-30
- Annual report 2023Filed via Bolagsverket / SCB · Period 2022-07-01 – 2023-06-30
- Annual report 2022Filed via Bolagsverket / SCB · Period 2021-07-01 – 2022-06-30
- Annual report 2021Filed via Bolagsverket / SCB · Period 2020-07-01 – 2021-06-30
No data on file.
| Name | Role | Member since |
|---|---|---|
| Current (2) | ||
| Deputy Board Member | 2025 | |
| Board of Directors | 2022 | |
| Former (1) | ||
| Deputy Board Member | 2022 – 2025 | |
No shareholder data available.
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
No registered parent or subsidiaries
Board members of AGRENIUS LUNGMEDICIN AB also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Thomas Erik Agrenius Gustafsson | Deputy Board Member | 0 companies |
| Sten Lennart Agrenius | Deputy Board Member | 0 companies |
| Olga Veronica Agrenius | Board of Directors | 0 companies |